Stacey Tinianov: Exploring Promises and Pitfalls of Multi-Cancer Early Detection Testing
Stacey Tinianov, Co-founder of Advocates for Collaborative Education (ACE), shared a post by National Coalition for Cancer Survivorship on LinkedIn, adding the following:
“Excited for next week’s chat with Dr Otis Brawley in this National Coalition for Cancer Survivorship webinar! We will share our perspectives on the promises, as well as the pitfalls, of current Multi-Cancer Early Detection (MCED) testing including what these tests are, what they are not, and what individuals may want to consider in the big picture of cancer screening.”
Quoting National Coalition for Cancer Survivorship’s post:
“The field of multi-cancer early detection (MCED) is evolving, offering both promise and complexity in cancer screening.
Join us for an insightful webinar featuring Dr Otis Brawley and Stacey Tinianov, MPH, BCPA as they discuss the current state of MCED tools, their role in broader screening efforts, and the clinical implications of early detection. If you’re a healthcare professional or researcher, this is a must-attend event to stay informed on the latest advancements in cancer detection.
Register now.”
Stacey Tinianov is a board-certified patient advocate. As a co-founder of Advocates for Collaborative Education (ACE), Tinianov advises companies like Ciitizen and CareLoop, ensuring patient-centricity in their initiatives.
She serves on boards such as Bay Area Young Survivors (BAYS) and Camp Kesem SCU, advocating for cancer survivors’ needs. Tinianov’s influence also reaches policy and research spheres, contributing to organizations like the National Coalition for Cancer Survivorship (NCCS) and UCSF’s Breast Science Advocacy Core (BSAC).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023